Innovation & Research

A person scrolls on a smartphone
The teams in this year’s Randall Family Big Idea Competition couldn’t be stopped—competitors asked the organizers to go digital, and they obliged. See the winners.
A depiction of the coronavirus
The Clinical and Translational Science Institute at the University of Pittsburgh has awarded $900,000 to 17 studies to address different aspects of the COVID-19 pandemic.
a man in a hospital bed and a monitor next to it with CO2 and blood flow numbers on it
The Hemolung respiratory assist system, which was designed at the University of Pittsburgh, has been granted emergency use authorization from the FDA to treat lung failure caused by COVID-19.
A teenager takes a selfie while lying on a bed next to a computer
Pitt psychologist Sophia Choukas-Bradley has developed a scale for gauging body image consciousness, and using it, she’s found that teens think about the way they present to an online audience, even in their offline moments.
Emily Oby in a white tank top holding equipment
Researchers at Pitt and Carnegie Mellon University are finding out how the brain learns new tasks, which could help people who have suffered injuries to the nervous system. Their latest findings were published today in Nature Biomedical Engineering.
A person in a blue shirt with a white apron checks a tablet
The Pitt institute is offering free resource guides, webinars and advice on federal and state programs to help small business owners through the pandemic.
Zachary Horton in a brown jacket
From ancient Egyptian war games to Candy Land and Settlers of Catan, Pitt researcher Zachary Horton explains the evolution of board games and why they’re more popular today than ever, just in time for National Board Game Day on April 11.
Salk administering a shot to a nurse
April 12 marks 65 years since the polio vaccine, developed by a team led by Pitt’s Jonas Salk, was deemed safe and effective. Its success helped move vaccine science forward, and gives hope for a COVID-19 vaccine today.
A novel clinical trial developed by researchers at the University of Pittsburgh School of Medicine launched this week at UPMC to address one of the most important debates during the COVID-19 pandemic: How should doctors decide between quickly adopting new therapies and waiting until they are tested in longer clinical trials?
A person in a white coat and black tie holds a patch on their finger
University of Pittsburgh School of Medicine scientists announced a potential vaccine against SARS-CoV-2, the new coronavirus causing the COVID-19 pandemic. When tested in mice, the vaccine, delivered through a fingertip-sized patch, produces antibodies specific to SARS-CoV-2 at quantities thought to be sufficient for neutralizing the virus.